Boehringer Ingelheim and HealthPrize Technologies today announced the expansion of the RespiPoints digital support program to anyone taking one of several Boehringer Ingelheim medicines, including select medicines available in the Respimat inhaler.
About Vishal Khanna
This author has yet to write their bio.Meanwhile lets just say that we are proud Vishal Khanna contributed a whooping 18 entries.
Entries by Vishal Khanna
The two companies extend their collaboration to integrate West’s drug delivery systems with HealthPrize’s digital adherence and engagement platform.
We’re packing our bags – and our booth shwag – and getting ready for the Spring season of life science marketing conferences. If you’d like to learn more about HealthPrize, we’d like to learn more about your challenges and goals.
Medication non-adherence is one of the most serious problems in healthcare, posing a heavy financial impact on all constituencies.
The pharmaceutical services leader will help guide the company’s growth and expansion in the life sciences industry
Former inVentiv executive brings key pharmaceutical services sector experience to HealthPrize’s board.
The ZS Associates principal will bring her expansive patient engagement and multi-channel marketing experience to HealthPrize’s board
Cost has been one of pharma’s key adherence tactics. But what would happen if we gave away medications for free?
Learn how HealthPrize’s client services team partners with brand marketers to launch digital adherence programs that deliver measurable results.
Campaigns to patients and healthcare providers alike are carefully designed to increase the number of prescriptions being written for our medications. But what happens after that first prescription?